PRA ICR Documents
Skip to main content
An official website of the United States government
The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Search:
Agenda
Reg Review
ICR
ICR Documents
Supporting Statement A
Document
Date Uploaded
CMS-10396_Medication Therapy_Supporting Statement.docx
12/11/2020
Supporting Statement B
Document
Date Uploaded
Supplementary Documents
Title
Document
Document Type
Date Uploaded
Crosswalk
2017to2020_crosswalk_508.pdf
Supplementary Document
12/11/2020
Public Comments
Author Name
Comment Document
Author Affiliation
Sponsoring Org.
Type
Category
Date of Comment
Date Comment Received
Hoisington, Tracy
20200320 UCare Comments on CMS-10396.pdf
Federal Government Relations Specialist
UCare
Email
Simple
04/20/2020
04/20/2020
Anonymous
2021 proposed standard format change comments.pdf
Email
Simple
04/23/2020
04/23/2020
Anonymous
CMS Communications Solicitation for Comments Notice ID 1205563.pdf
Cigna
Email
Simple
04/24/2020
04/24/2020
Cantrell., Susan
AMCP Comments MTM Standardized Format.pdf
Chief Executive Officer
AMCP
Email
Simple
04/24/2020
04/24/2020
Vogler, Abbie
CMS-10396 Request for Comments_MTM Standardized Format Changes.pdf
VP, Business Development
Genoa Healthcare
Email
Simple
04/24/2020
04/24/2020
Plumey, Myra
CMS-2020-0016 - CMR.pdf
Email
Simple
04/24/2020
04/24/2020
Spears, Jamie
Comment Form_MTM.xlsx
Email
Simple
04/24/2020
04/24/2020
Hanson, Alison
CMS-10396_MTM Standardized Format_Comments.pdf
Supervisor, Medicare Programs
HealthPartners
Email
Simple
04/24/2020
04/24/2020
Brandt, Nicole
Comment Letter CMS-MTM-SF_UM_LAMY.pdf
Executive Director, Lamy Center on Drug Therapy and Aging
University of Maryland School of Pharmacy
Email
Simple
04/24/2020
04/24/2020
Markus, Dani
Comments-to-CMS-Standardized-Format.pdf
Vice President of Quality
OutcomesMTM
Email
Simple
04/23/2020
04/23/2020
Stretch , Kaitlin
Comments on MTM Standardized Format.pdf
Manager of Regulatory Oversight and Compliance
BCBS MI
Email
Simple
04/23/2020
04/23/2020
Odrzywolski, Dawn
IHA MTM Comments to CMS-10396 4_24_2020.pdf
Vice President, Medicare Programs
Independent Health
Email
Simple
04/24/2020
04/24/2020
Regan, Pam
Gateway.pdf
Gateway Healthplan
Email
Simple
04/23/2020
04/23/2020
Banks, Nichelle
PerformRx Comments for Medication Therapy Management Program Improvements 4_1_20.pdf
Manager, Government Programs Compliance
Perform RX
Email
Simple
04/06/2020
04/06/2020
Markus, Dani
National MTM Advisory Board Comments to CMS - Proposed Standardized Format Changes FINAL.pdf
Vice President of Quality
OutcomesMTM
Email
Simple
04/24/2020
04/24/2020
Schuster, Shannon
UHC Comments - Medication Therapy Management Program Improvements.pdf
Director, Regulatory Affairs
United Healthcare
Email
Simple
04/24/2020
04/24/2020
Anonymous
Revisions to Part D MTM PHA (1).pdf
Providence Health Assurance
Email
Simple
04/15/2020
04/15/2020
Galvin, Jane
2020_04_21 BCBSA Comments on MTM Program Improvements - Final.pdf
Managing Director, Regulatory Affairs
BlueCross BlueShield Association
Email
Simple
04/23/2020
04/23/2020
Phillips, Annie
2020_4_16_MTMP Improv Stdz Form-CalOptima comments.pdf
Orange County Health Authority, dba CalOptima
Email
Simple
04/23/2020
04/23/2020
Blank fields in records indicate information that was not collected or not collected electronically prior to July 2006.
Something went wrong when downloading this file. If you have any questions, please send an email to risc@gsa.gov.